SCHEMBL732959

SCHEMBL732959

CC1OC(=O)[C@H](C)OC1=O

nearest known ligand 0.41

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.41
CA9 Q16790 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TAS2R46 P59540 2/20 0.31
MAOA P21397 1/20 0.30
PARP1 P09874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8104271 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL44996 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL439067 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL682255 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL15034 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL15195848 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL2860232 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
Methane SCHEMBL1276943 0.96 CA1 (0.39) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL2314693 0.96 CA1 (0.39) CA1CA9SMN1; SMN2MEN1KMT2A
Ammonia Solution, Strong SCHEMBL17351919 0.96 CA1 (0.39) CA1CA9SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 352 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12558089-B2 Indirect attachment of a needle to a mesh suture NORTHWESTERN UNIVERSITY (US) 2026-02-24 US claimed
US-20240245399-A1 INDIRECT ATTACHMENT OF A NEEDLE TO A MESH SUTURE NORTHWESTERN UNIVERSITY (US) 2024-07-25 US claimed
US-11890003-B2 Indirect attachment of a needle to a mesh suture NORTHWESTERN UNIVERSITY (US) 2024-02-06 US claimed
EP-3834857-B1 SEGMENTED, P-DIOXANONE-RICH, POLY(P-DIOXANONE-CO-EPSILON-CAPROLACTONE) COPOLYMERS FOR MEDICAL APPLICATIONS AND DEVICES MADE THEREFROM ETHICON INC (US) 2023-09-06 EP claimed
US-11505645-B2 Curable adhesive compositions and use thereof HENKEL AG & CO., KGAA (DE) 2022-11-22 US claimed
US-20220330939-A1 SUTURE NORTHWESTERN UNIVERSITY (US) 2022-10-20 US claimed
US-20220235176-A1 METHOD FOR PRODUCING POLYETHER ESTER CARBONATE POLYOLS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-07-28 US claimed
CN-105764539-B Absorbent polymer blend compositions having precisely controllable absorption rates, methods of processing, and dimensionally stable medical devices therefrom 伊西康有限责任公司 2022-03-11 CN claimed
US-20220054127-A1 INDIRECT ATTACHMENT OF A NEEDLE TO A MESH SUTURE NORTHWESTERN UNIVERSITY (US) 2022-02-24 US claimed
CN-114026148-A Method for producing polyether ester carbonate polyols 科思创知识产权两合公司 2022-02-08 CN claimed
EP-2556037-B1 HEALING AGENT FOR SELF-HEALING CEMENTIOUS MATERIAL UNIV DELFT TECH (NL) 2017-11-01 EP claimed
US-20160347658-A1 HEALING AGENT FOR SELF-HEALING CEMENTIOUS MATERIAL TECHNISCHE UNIVERSITEIT DELFT (NL) 2016-12-01 US claimed
US-8911549-B2 Healing agent for self-healing cementious material TECHNISCHE UNIVERSITEIT DELFT (NL) 2014-12-16 US claimed
US-20130112114-A1 HEALING AGENT FOR SELF-HEALING CEMENTIOUS MATERIAL TECHNISCHE UNIVERSITEIT DELFT 2013-05-09 US claimed
EP-1789470-B1 COPOLYETHERESTER COMPOSITIONS CONTAINING HYDROXYALKANOIC ACIDS AND SHAPED ARTICLES PRODUCED THEREFROM DU PONT (US) 2012-10-31 EP claimed
US-7144972-B2 Copolyetherester compositions containing hydroxyalkanoic acids and shaped articles produced therefrom E. I. DU PONT DE NEMOURS AND COMPANY (US) 2006-12-05 US claimed
US-20060009611-A1 Copolyetherester compositions containing hydroxyalkanoic acids and shaped articles produced therefrom E. I. DU PONT DE NEMOURS AND COMPANY 2006-01-12 US claimed
US-6455285-B1 Enzyme-catalyzed modifications of macromolecules in organic solvents THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2002-09-24 US claimed
US-6448050-B1 Enzyme-catalyzed modifications of macromolecules in organic solvents THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2002-09-10 US claimed
US-6210936-B1 Enzyme-catalyzed modifications of macromolecules in organic solvents UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2001-04-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12558089-B2 Indirect attachment of a needle to a mesh suture MYH9, KRT18, DSP CA1 3007/4885CA9 992/4885SMN1; SMN2 2608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.